Active growth signalling promotes cancer cell sensitivity to the CDK7 inhibitor ICEC0942
Authors:
- Georgina SavaGSGeorgina Sava
- Karla VuinaKVKarla Vuina
- Caroline HuardCHCaroline Huard
- Leticia MeneguelloLMLeticia Meneguello
- Jasmin Coulombe-HuntingtonJCJasmin Coulombe-Huntington
- Thierry BertomeuTBThierry Bertomeu
- R.J. MaizelsRMR.J. Maizels
- Josh LauringJLJosh Lauring
- Mike TyersMTMike Tyers
- Simak AliSASimak Ali
- Cosetta BertoliCBCosetta Bertoli
Preprint
Abstract
CDK7 has a central role in promoting cellular proliferation, through the activation of the mitotic CDKs, and by driving global gene expression, through targeting RNA polymerase II. Several recently developed CDK7 inhibitors (CDK7i) have been shown to be non-toxic and to limit tumour growth for a number of cancer cell types and are now in Phase I/II clinical trials. However, the mechanisms underlying the sensitivity of particular cancer cells to CDK7 inhibition remain largely unknown. To improve the outcome of individual patients and increase the chances of successful CDK7i approval, we assessed which fundamental cellular processes determine sensitivity to CDK7 inhibition, using the highly specific CDK7 inhibitor ICEC0942. Our data shows that selective CDK7 inhibition acutely arrests cells in the G1 phase of the cell cycle, which over time leads to senescence. Through a genome-wide CRISPR knock-out chemogenetic screen we identified active mTOR (mammalian target of rapamycin) signalling, as an important determinant of ICEC0942-induced senescence and show that a cancer-associated mutation that promotes cell growth can increase sensitivity to ICEC0942. Our work indicates that cellular growth is an important predictive marker for sensitivity to CDK7i.Keywords
This publication has 28 references indexed in Scilit:
- The CDK Network: Linking Cycles of Cell Division and Gene ExpressionGenes & Cancer, 2012
- REVIGO Summarizes and Visualizes Long Lists of Gene Ontology TermsPLOS ONE, 2011
- Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivoNature Protocols, 2009
- An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1Journal of Biological Chemistry, 2009
- GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene listsBMC Bioinformatics, 2009
- Growth stimulation leads to cellular senescence when the cell cycle is blockedCell Cycle, 2008
- Discovering Motifs in Ranked Lists of DNA SequencesPLOS Computational Biology, 2007
- Targeting the Cell Cycle: A New Approach to Cancer TherapyJournal of Clinical Oncology, 2005
- What has senescence got to do with cancer?Cancer Cell, 2005
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990